# US 2009/0270335 A1 · Collyrium for dry eye

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0270335 A1
- Document ID: US20090270335A1
- Status: Published application
- Kind: A1
- Application number: 12/441,749
- Filed: 2007-09-18
- Published: 2009-10-29
- Earliest claimed: 2006-09-18
- Assignees: Aqueous Pharma Limited
- Inventors: Frank J. Holly; Joel S. Echols
- Web page: https://patentgrep.com/patent/US20090270335A1

## CPC

- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A composition for treating dry eye includes eledoisin formulated in an ester form and a phospholipid formulated in a micellar form.

## Claims

### Claim 1

A composition comprising:
eledoisin formulated in an ester form; and
a phospholipid formulated in a micellar form.

### Claim 2 (depends on 1)

The composition of claim 1 wherein said phospholipid is lecithin.

### Claim 3 (depends on 1)

The composition of claim 1 wherein said phospholipid is dodecyl-phosphocholine.

### Claim 4 (depends on 1)

The composition of claim 1 further comprising fully hydrolyzed polyvinyl acetate.

### Claim 5 (depends on 1)

The composition of claim 1 further comprising partially hydrolyzed polyvinyl acetate.

### Claim 6 (depends on 1)

The composition of claim 1 further comprising polyvinyl-pyrrolidone.

### Claim 7 (depends on 1)

The composition of claim 1 wherein the concentration of said eledoisin is about 0.1 percent (w/w) to about 1.0 percent (w/w).

### Claim 8 (depends on 7)

The composition of claim 7 wherein the concentration of said phospholipid is about 0.005 percent (w/w) to 0.05 percent (w/w).

### Claim 9 (depends on 8)

The composition of claim 8 further comprising polyvinyl alcohol that is about 96% to about 99% hydrolyzed, and polyvinyl acetate that is about 85% to 90% hydrolyzed, and polyvinyl pyrrolidone.

### Claim 10 (depends on 9)

The composition of claim 9 wherein the concentration of said polyvinyl alcohol about 0.5 percent (w/w) to about 10 percent (w/w), the concentration of said polyvinyl acetate is about 0.5 percent (w/w) to about 10 percent (w/w), and the concentration of said polyvinyl pyrrolidone is about 1 percent (w/w) to about 4 percent (w/w).
